News

FDA issues urgent recall for cucumbers over deadly contamination
The US Food and Drug Administration upgraded their June alert, recalling dozens of boxes of cucumbers to the agency's highest ...
FDA gives full approval to Moderna COVID shot for at-risk kids
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making ...
FDA, in policy shift, publishes some drug rejection letters
The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...
FDA ends recall of salmonella-contaminated brown eggs
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
FDA Blueberry Recall Has Now Turned Deadly: Who Are The Most Vulnerable? Here's What You Need To Know
US blueberry recall upgraded to deadly risk due to listeria. UK consumers urged to check imports and watch for symptoms.
Food Safety News5h
FDA administrator declares first 100 days in office a success
To mark his first 100 days as head of the FDA, Martin Makary is touting his efforts to change the agency’s operations. The Food and Drug Administration ...
Stockhead on MSN10h
Neurizon on track to lift FDA clinical hold on ALS drug, eyes Healey trial in Q4 CY25
Neurizon Therapeutics has announced progress to lift a US Food and Drug Administration (FDA) clinical hold on its lead drug .
Food Safety News5h
FDA increases enforcement of regs for imports including seafood, papayas, cantaloupe and more
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...
FDA's Blueberry Recall For Listeria Gets Highest Risk Level: What Dangers Should You Be Aware Of
FDA issues Class I recall for organic blueberries due to Listeria risk. Learn which batches are affected and how to stay safe ...
Clinical Trials Arena on MSN1d
FDA approves Purespring’s application for Phase I/II trial of IgAN treatment
The US FDA has approved Purespring Therapeutics’ IND application for PS-002, allowing the company to begin a Phase I/II trial.
Asianet Newsable on MSN1h
Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy
The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical ...